Molecular Cardioprotection: How Pediatric Myosin Inhibition Redefines the Economics of Congenital Heart Care
Dr. Dereck Mush, MD, MBA
What they do
iCardio.ai builds machine learning algorithms to automate the analysis and reporting of echocardiogram videos. The company's technology aids clinical laboratories and medical imaging networks in speeding up the detection of cardiac conditions like aortic stenosis.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Echocardiography AI
- Product type
- Software as a medical device
- Stage
- Seed
- Headquarters
- Los Angeles, USA
- Region
- North America
- Founded
- 2019
- Total funding
- $4M raised
Notable investors: Y Combinator, Mucker Capital, K9 Ventures, Physician Investors.
Also in Cardiovascular
Related on The Signal
Dr. Dereck Mush, MD, MBA
Opportunistic Valvular Screening: How Routine ECG-AI Expands the Structural Heart Pipeline
Dr. Dereck Mush, MD, MBA
Top 25 Cardiologists to Follow on LinkedIn in 2026
Dr. Dereck Mush, MD, MBA
The ECG-to-Echo Pathway: Where Tempus ECG-MR Must Prove Its Value
Dr. Dereck Mush, MD, MBA